Kevin Foley
Direktor/Vorstandsmitglied bei Triad Life Sciences, Inc.
Profil
Kevin Foley currently works as a Director at Triad Life Sciences, Inc.
Aktive Positionen von Kevin Foley
| Unternehmen | Position | Beginn |
|---|---|---|
Triad Life Sciences, Inc.
 Triad Life Sciences, Inc. Medical SpecialtiesHealth Technology Part of Convatec Group Plc, Triad Life Sciences, Inc. is a biotech company based in Memphis, TN. The company is focused on developing and commercializing innovative, efficacious and affordable biomaterials for treating complex surgical and chronic wounds. Triad recently received FDA clearance to market Innovamatrix™, a next-generation extracellular matrix (ECM) wound care device. The company was founded in 2017 by Russell I. Olsen, who has been the CEO since then. Triad Life Sciences was acquired by Convatec Group Plc on March 14, 2022 for $450 million. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Triad Life Sciences, Inc.
Triad Life Sciences, Inc. Medical SpecialtiesHealth Technology Part of Convatec Group Plc, Triad Life Sciences, Inc. is a biotech company based in Memphis, TN. The company is focused on developing and commercializing innovative, efficacious and affordable biomaterials for treating complex surgical and chronic wounds. Triad recently received FDA clearance to market Innovamatrix™, a next-generation extracellular matrix (ECM) wound care device. The company was founded in 2017 by Russell I. Olsen, who has been the CEO since then. Triad Life Sciences was acquired by Convatec Group Plc on March 14, 2022 for $450 million. | Health Technology |
